Form 10 Explorer
10-Q
Quarterly Report
BIOMERICA, INC.

BMRA

NASDAQ

CIK: 73290

File #: 001-37863

Period End: Nov 30, 2025

Fiscal Year: 2026

View on EDGAR
Balance Sheet
35 line items · 2 periods
XBRL
ItemNov 30, 2025May 31, 2025
Assets
Current Assets:
Cash and Cash Equivalents
2,543,0002,399,000
Accounts Receivable
947,000731,000
Inventory
1,524,0001,490,000
Other Non-Operating Current Assets
177,000255,000
Total current assets
5,191,0004,875,000
Property, Plant and Equipment
105,000135,000
MEXICO
8,00010,000
Operating Lease Right-of-Use Asset
264,000429,000
Cash and Cash Equivalents
165,000165,000
Polish Distributor
165,000—
Intangible Assets
219,000228,000
Other Non-Operating Non-Current Assets
90,000113,000
Total Assets
6,034,0005,945,000
Liabilities and Shareholders’ Equity
Current Liabilities:
Accounts Payable
740,000672,000
Other Current Liabilities
545,000655,000
Other Current Liabilities
30,00055,000
Operating Lease Liability, Current
284,000358,000
Total current liabilities
1,599,0001,740,000
Operating Lease Liability, Non-Current
—100,000
Total Liabilities
1,599,0001,840,000
Shareholders’ Equity:
Total Stockholders' Equity
236,000203,000
Total Stockholders' Equity
58,788,00057,175,000
Total Stockholders' Equity
(103,000)(105,000)
Total Stockholders' Equity
(54,486,000)(53,168,000)
Total Shareholders’ Equity
4,435,0004,105,000
Common Stock
236,000203,000
Additional Paid-in Capital
58,788,00057,175,000
AOCI Attributable to Parent
(103,000)(105,000)
Retained Earnings
(54,486,000)(53,168,000)
Total Liabilities and Shareholders’ Equity
6,034,0005,945,000